Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Accenture
Moodys
Farmers Insurance
Covington
Citi
Medtronic
Harvard Business School
McKesson

Generated: July 22, 2018

DrugPatentWatch Database Preview

Ibutilide fumarate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for ibutilide fumarate and what is the scope of ibutilide fumarate freedom to operate?

Ibutilide fumarate
is the generic ingredient in two branded drugs marketed by Pharmacia And Upjohn, Luitpold, and Mylan Institutional, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for ibutilide fumarate. Two suppliers are listed for this compound.
Summary for ibutilide fumarate
Pharmacology for ibutilide fumarate
Drug ClassAntiarrhythmic
Synonyms for ibutilide fumarate
( inverted exclamation markA)-N-[4-[4-(Ethylheptylamino)-1-hydroxybutyl]phenyl]-methanesulfonamide hemifumarate salt
(+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfoanilide (E)-2-butenedioate (2:1)
(+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfonanilide fumarate (2:1) (salt)
(+-)-N-(4-(4-(Ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide (E)-butenedioate
(+/-)-N-[4-[4-(Ethylheptylamino)-1-hydroxybutyl]phenyl]-methanesulfonamide hemifumarate salt
(+/-)-N-[4-[4-(Ethylheptylamino)-1-hydroxybutyl]phenyl]methanesulfonamide hemifumarate
(E)-but-2-enedioic acid; N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide
122647-32-9
130350-52-6
2C20H36N2O3S.C4H4O4
647I329
AB0016835
AB2000520
AC1NQXZ2
AKOS015896070
AS-15378
bis(N-(4-(4-(ethyl(heptyl)amino)-1-hydroxybutyl)phenyl)methanesulfonamide) fumarate
bis(N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide); but-2-enedioic acid
C20H36N2O3S??0.5C4H4O4
CAS-122647-32-9
CCG-220685
CHEBI:5857
CHEMBL2355456
Corvert
Corvert (TN)
D00648
DSSTox_CID_28578
DSSTox_GSID_48652
DSSTox_RID_82849
DTXSID8048652
EN300-122354
FUMARIC ACID; BIS(IBUTILIDE)
HSDB 7926
I06-1701
Ibutilide (fumarate)
Ibutilide fumarate (USAN)
Ibutilide Fumarate [USAN]
Ibutilide fumarate, United States Pharmacopeia (USP) Reference Standard, monograph mol wt. 885.23 ([(C20H36N2O3S)2 . C4H4O4])
Ibutilide hemifumarate
Ibutilide hemifumarate salt
Ibutilide hemifumarate salt, >=98% (HPLC)
ibutilide, fumarate salt (2:1), (+-)-isomer
LP018754
LS-90124
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (+-)-, (E)-2-butenedioate (2:1) (salt)
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (+-)-,(E)-2-butenedioate (2:1) (salt)
Methanesulfonamide, N-[4-[4-(ethylheptylamino)-1-hydroxybutyl]phenyl]-, (2E)-2-butenedioate (2:1)
MFCD01715410
MolPort-019-939-237
N-[4-[4-(ethyl-heptyl-amino)-1-hydroxy-butyl]phenyl]methanesulfonamide fumarate
NCGC00181771-01
NE46026
P113
s2118
SC-94637
SCHEMBL42073
Tox21_113006
U 70226E
U-70226E

US Patents and Regulatory Information for ibutilide fumarate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional IBUTILIDE FUMARATE ibutilide fumarate INJECTABLE;INJECTION 090643-001 Jan 11, 2010 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Luitpold IBUTILIDE FUMARATE ibutilide fumarate INJECTABLE;INJECTION 090240-001 Jan 11, 2010 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Institutional IBUTILIDE FUMARATE ibutilide fumarate INJECTABLE;INJECTION 090924-001 Jan 11, 2010 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CORVERT ibutilide fumarate INJECTABLE;INJECTION 020491-001 Dec 28, 1995 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Daiichi Sankyo
Baxter
Farmers Insurance
Citi
Colorcon
Mallinckrodt
US Army
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.